Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness Assessment of Riluzole in the Prevention of Oxaliplatin-induced Peripheral Neuropathy: A Phase II Randomized Study by UNICANCER With the Cooperation of AFSOS

NCT03722680 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.

NCT NCT03722680
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03722680 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness Assessment of Riluzole in the Prevention of Oxaliplatin-induced Peripheral Neuropathy: A Phase II Randomized Study by UNICANCER With the Cooperation of AFSOS
Lead sponsor
UNICANCER
Phase
Phase 2
Overall status
Suspended
Start date
October 28, 2020
Completion date
December 31, 2026
Enrollment
80 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

oxaliplatin-induced peripheral neuropathy